Management Team

Mr. Pursglove, is an accomplished executive and entrepreneur with over a decade of experience across mergers and acquisitions, public and private capital markets, strategic growth, and operational leadership. His career spans multiple sectors, including technology, logistics, customer experience, sports, and marketing, where he has consistently delivered results by driving innovation, scaling operations, and building value-driven organizations. Mr. Pursglove is widely regarded for his forward-thinking leadership, entrepreneurial mindset, and deep understanding of how to build scalable infrastructure, raise capital, and execute on transformative business strategies in both public and private market environments.

Mr. van der Baan, 51, has more than 20 years of experience in the biotechnology industry, with a key focus on oncology and diagnostics. Most recently, he was the Chief Clinical and Business Development Officer of Agendia, Inc. in Irvine, California and Amsterdam, Netherlands. In that role, Mr. van der Baan was instrumental in the initiation and execution of numerous clinical trials that led to full commercialization and adoption of precision molecular oncology diagnostics. He initiated the launch of Agendia’s business operations in the United States and has broad knowhow in clinical development, both in the United States and in Europe.

Peter Stazzone brings to LIXTE more than 20 years of relevant financial management experience in publicly traded and privately owned companies, where he has been instrumental in guiding corporate transformations, including M&A, raising capital, implementing financial controls, and managing the public company reporting process. He has served as CFO for several companies, including Beyond Commerce, Inc., Strainz, Inc. and Voice Telecom.